HCS facility at TIGEM

High Content Screening Facility at TIGEM (Telethon Institute of Genetics and Medicine) headed by Prof. Diego Luis Medina

[HCS facility at TIGEM @HCS_Tigem]

I am grateful to the NCL STIFTUNG for allow us to move forward our studies too understand the pathophysiology of BD and develop new therapies based in small molecules. https://t.co/Utbg3dOtpT

[HCS facility at TIGEM @HCS_Tigem]

@CianfVale @nclStiftung @Telethonitalia @Tigem_Telethon Thanks a lot Valentina!

[HCS facility at TIGEM @HCS_Tigem]

I am honored to have received the 12th NCL Research award from @nclStiftung during the 19th National NCL Congress at Hamburg. Many thanks to all collaborators Chiara Soldati, Irene Lopez-Fabuel, Juan P. Bolanos, @Telethonitalia @Tigem_Telethon @HCS_Tigem

[HCS facility at TIGEM @HCS_Tigem]

@DecressacLab @nclStiftung @Telethonitalia @Tigem_Telethon Thanks Michael!

[ESGLD @ESGLD_tweets]

Happy to have you and learn more on your exciting results 👏🏻

[HCS facility at TIGEM @HCS_Tigem]

Proud to work at the @HCS_Tigem with @Anto_Capuozzo and Giuseppina Grieco, both selected to present their last results studying mucopolysaccharidosis type IIIA and Mucolipidosis type IV in the 24th #Esgldworkshop. Thanks, @Tigem_Telethon, @Telethonitalia, and @CureSanfilippoF

[HCS facility at TIGEM @HCS_Tigem]

@EDeLeonibus @CNRsocial_ Very proud to work with all these amazing researchers and TIGEM facilities @Edeleonibus #AnnaScottoRosato#ChristianGrimm #DominikPaquet #SandroMontefusco to identify small molecule therapies to tackle LSDs. Thanks to Telethon for supporting our @HCS_Tigem

[HCS facility at TIGEM @HCS_Tigem]

@Tigem_Telethon @nclStiftung I would like to express my sincere gratitude to @nclStiftung and Joachim Herz Stiftung for funding our research. Thanks to this award we will be able to continue our studies to identify new therapies for Batten Disease

[HCS facility at TIGEM @HCS_Tigem]

@rushika_perera @ASCBiology @PDClab Congratulations!!!

[EMBO Mol. Medicine @EmboMolMed]

Repurposing of #tamoxifen ameliorates CLN3 and CLN7 disease phenotype in cellular and murine models

@Tigem_Telethon @HCS_Tigem @usal

#BattenDisease #tamoxifen

-> Read #openaccess: https://t.co/Zmsa7J1Bau

[HCS facility at TIGEM @HCS_Tigem]

Proud to share our work “ Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype” published today in #Embo_Molecular_Medicine. Thanks a lot to #Tigem_telethon, #Horizon2020 funding and our great consortium #BatCure. https://t.co/4cilKnbhbC

[HCS facility at TIGEM @HCS_Tigem]

@BioRender

[Tigem Telethon @Tigem_Telethon]

Thanks #DiegoLuisMedina for his #TigemOnlineSeminar on LSDs and therapeutic options. This image shows the the key milestones, publications and funding sources of the high content screening facility since 2011. Technology updates and patenting activities are also represented here!

[HCS facility at TIGEM @HCS_Tigem]

Some 'behind the scenes' of our high throughput #analysis protocol which we use to screen #COVID19 tests. This work supports the #COVID19 team here at @Tigem_Telethon to identify genetic variants.
#coronavirus #highthroughput #screening #geneticvariants

[HCS facility at TIGEM @HCS_Tigem]

These results have been generated in our HCSF at Tigem with the support of the Horizon 2020 program during the last 3 years! Thank you BatCure and Chiara for this work!

[Tigem Telethon @Tigem_Telethon]

Congratulations to Chiara Soldati from @HCS_Tigem for winning the best presentation award during the 6th JNCL Young Investigator Symposium @nclStiftung. She earned it “for her dedicated presentation on repositioning of drugs to treat #Batten disease”. #TigemTalent